Details
Atorvacor Indications
- Reduce the risk of fatal manifestation of coronary heart disease and nonfatal myocardial infarction;
- Reducing the risk of stroke;
- Reducing the risk of angina and the need for revascularization procedures implementation.
Patients with clinical symptoms of coronary disease, atorvastatin is indicated for:
- Reduce the risk of nonfatal myocardial infarction;
- Reduce the risk of fatal and nonfatal stroke;
- Reduce risk during revascularization procedures;
- Reducing the risk of hospitalization for congestive heart failure;
- Reducing the risk of strokes.
Children (10-17 years)
Atorvacor is appointed as an adjunct to diet to reduce total cholesterol, low-density lipoprotein, and apolipoprotein B in boys and girls postmenarhialnyy period, aged 10 to 17 years with heterozygous familial hypercholesterolemia, even subject to an adequate diet
Dosage & Administration
Before therapy with Atorvacor®, you should try to achieve adequate control of hypercholesterolemia by diet, increased physical activity, weight loss in obese patients for treatment and other related diseases.
Treatment against the background of cholesterol-lowering diet. The drug is administered at a dose of 10-80 mg 1 time a day, every day, at any time of the day at the same time, regardless of the meal.
The initial and maintenance dose set individually according to the initial levels of LDL cholesterol goal of therapy and efficiency. The recommended starting dose is 10 mg.
If necessary, the dose is increased gradually at intervals of 2-4 weeks or more controlling lipid levels in blood plasma. The maximum daily dose is 80 mg.
